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Mad Cows Meet Psi-chotic Yeast: Minireview
The Expansion of the Prion Hypothesis
Susan Lindquist of a cross between [psi2] and [PSI1] cells; [URE3] is
more variable. These patterns of inheritance couldHoward Hughes Medical Institute
readily be explained if the traits were encoded by mito-Department of Molecular Genetics and Cell Biology
chondria, plasmids, or viruses. But efforts tomap [PSI1]The University of Chicago
and [URE3] to such conventional genetic elements, orChicago, Illinois 60637
to find new, nonchromosomal nucleic acids to account
for them, failed. Another common feature of [PSI1] and
Some of the most exciting concepts in science issue
[URE3] is that they are metastableÐinherited by most
from the unexpected collision of seemingly unrelated
progeny, but lost at a higher rate than expected for
phenomena. In 1994, Reed Wickner initiated such a colli-
mutationÐand lost at very high rates when cells are
sion by proposing that two baffling problems in yeast
grown on low concentrations of the protein denaturant
genetics could be explained by a hypothesis previously guanidine hydrochloride. When cells are cured of these
invoked to explain the transmission of certain neurode- elements, they can later reappearÐnot a trait expected
generative diseases in mammals, the prion hypothesis
from a nuclei acid vector (see Cox, 1988, and Wickner,
(Wickner, 1994). In one fell swoop, a series of increas-
1996, for review).
inglybaffling observationsaccumulated by yeast geneti- A more telling feature is that [PSI1] and [URE3] bear
cists for 30 years became intelligible. Wickner's pro- unusual and intimate relationships to proteins encoded
posal was grounded on geneticobservations, but recent by chromosomal genes. For [PSI1] this protein is Sup35,
work adds biochemical and cell biological support. The a subunit of the translation termination factor (Stansfield
case is now convincing, and its implications are broad. et al., 1995). For [URE3] it is Ure2, a protein that antago-
I will not discuss the mammalian prion work so ably nizes the action of the nitrogen-regulated transcription
covered by Art Horwich and Jonathan Weissman (1997 activator Gln3 (Wickner, 1996). These proteins share no
[this issue of Cell]), except as required to illuminate its sequence homology, but do share an unusual structural
connections to the yeast phenomena. In mammals, pri- feature (Figure 1). Their normal biological functions are
ons are postulated to produce spongiform encephalop- restricted to their carboxy-terminal domains and their
athies through the sole agency of an infectious protein. dispensable, amino-terminal domains have an unusual
This protein, PrP, is expressed in all mammalian brains. amino acid composition (Ter-Avanesyan et al., 1993;
It becomes infectious when it acquires a new conforma- Masison and Wickner, 1995). Some mutations in the
tion, one that interacts with other proteins of the same gene encoding Sup35 mimic the [PSI1] phenotype (Cox,
type and influences them to adopt the same conforma- 1988). Similarly, mutations in the gene encoding Ure2
tion. This chain reaction generates new infectious mate- mimic [URE3] (Aigle and Lacroute, 1975; Masison and
rial that spreads to adjacent cells and kills the affected Wickner, 1995). However, unlike [PSI1] and [URE3] phe-
neuron. notypes, the mutations are recessive and show 2:2 seg-
In yeast, prions do not spread from cell to cell and regation in meiosis. Thus, [PSI1] and [URE3] can't be
do not generally kill the cells harboring them. Rather, due to mutations in Sup35 and Ure2.
they are inherited by daughter cells from their mothers Two other types of analysis suggest, instead, that
(or passed between mating partners) and produce new these non-Mendelian elements are prion-like forms of
metabolic phenotypes. They behave, therefore, as heri- the two proteins. First, deleting the amino terminus of
table genetic elements. Like mammalian prions, how- Sup35 makes cells immune to the effects of [PSI1] (Ter-
ever, they appear to be based upon the ability of a Avanesyan et al., 1993) and deleting the amino terminus
protein that has acquired an abnormal conformation to of Ure2 makes cells immune to [URE3] (Masison and
influence other proteins of the same type to adopt the Wickner, 1995). Second, over-expressing Sup35 or
same conformation. Thus, in both cases, protein struc- Ure2, or just their amino termini, can induce the non-
tures act in a manner previously thought to be the unique Mendelian elements de novo (Masison and Wickner,
province of nucleic acids, in the one case as transmissi- 1995; Derkatch et al., 1996; Patino et al., 1996). More-
ble agents of disease, in the other as heritable determi- over, when these proteins are placed under the control
nants of phenotype. of other promoters, the appearance of the new elements
The Peculiar Genetics of [PSI1] and [URE3] depends upon the regulators of those promoters. Thus,
The yeast elements [PSI1] and [URE3] were discovered if sequences encoding aa 1±124 of Sup35 are placed
by Brian Cox (1965) and Francois Lacroute (Lacroute, under the control of the GAL1 promoter, [PSI1] appears
1971), respectively. [PSI1] enhances the suppression of in cells grown on galactose; if placed under the control
nonsense codons. [URE3] interferes with the nitrogen- of CUP1, it appears in cells exposed to copper; and
mediated repression of certain catabolic enzymes. What if placed under the control of a GRE (glucocorticoid
unites these otherwise unrelated elements is an unusual response element), it appears in response to glucocorti-
set of genetic properties that can now be explained by coids. Once cells have acquired [PSI1] or [URE3] in
a similar molecular mechanism. this manner, they continue to pass this trait on to their
The phenotypic traits produced by [PSI1] and [URE3] progeny for generation after generation, after the induc-
are dominant and inherited in a non-Mendelian manner ing agent is removedÐindeed, even after the overex-
(hence the capital letters and brackets in their names). pression plasmid is lost (Masison and Wickner, 1995;
Derkatch et al., 1996; Patino et al., 1996).[PSI1] is generally inherited by all the meiotic progeny
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Figure 1. Features of the Sup35 and Ure2
Proteins
The simplest explanation for these bizarre observa- of different protein structures rather than uponthe inher-
itance of different nucleic acids, is bolstered by thetions is that [PSI1] and [URE3] are due to the inheritance
of Sup35 and Ure2 proteins in an altered, prion-like, pivotal role that the protein chaperone Hsp104 plays in
the inheritance of [PSI1] (Chernoff et al., 1995; Patinostructural state (Figure 2) (Wickner, 1994, 1996; Tuite
and Lindquist, 1996). This would produce the same phe- et al., 1996). The normal role of Hsp104 (heat-shock
protein 104) is to promote the survival of cells exposednotypes as mutations in Sup35 and Ure2, because the
proteins carboxyl termini can't function in this state. to environmental stresses, such as high temperatures or
high concentrations of ethanol. It does so by promotingThese loss-of-function phenotypes would be dominant
and inherited in a non-Mendelian manner, because pro- conformational changes in stress-damage proteins,
leading to their reactivation (Parsell et al., 1994; Vogelteins in the [PSI1] or [URE3] conformations would inter-
act with new Sup35 or Ure2 proteins and encourage et al., 1995). When Hsp104 is placed under the control
of a heterologous promoter and expressed at a highthem to adopt the same altered structures. Assuming
that these structural alterations depend upon associa- level for a few hours at normal temperatures, it has little
noticeable effect, unless those cells harbor the [PSI1]tions of the amino-terminal domains would explain why
cells are immune to the elements when these are de- element. In that case, the vast majority of cells lose the
element (Chernoff et al., 1995). New, heritable [PSI1]leted. Overexpression of the amino-terminal domains
would make it more likely that the altered structures elements can be created in these cells by transient over-
expression of the amino-terminal domain of Sup35, butwould be established, but once they are established,
continued overexpression would no longer be required. they will again be lost if Hsp104 is transiently overex-
pressed. Because the only known function of Hsp104The Involvement of a Chaperone
This revolutionary hypothesis, that the inheritance of is to affect the conformational state of other proteins,
its ability to produce a heritable change in phenotypephenotypic traits can be based upon the transmission
upon transient overexpression strongly supports the hy-
pothesis that the inheritance of [PSI1] is due to the
inheritance of an altered protein structure.
Curiously, deleting the HSP104 gene also cures cells
of [PSI1] (Chernoff et al., 1995; Patino et al., 1996). In
fact, it produces a ªpsi-no-moreº phenotype, preventing
them from becoming [PSI1] even with overexpression
of Sup35. Thus, the maintenance of [PSI1] requires an
intermediate concentration of Hsp104; too much or too
little, and the element is lost. One model to explain these
data is that Hsp104 is required because it promotes a
conformational ªtransitionº state in Sup35 that facili-
tates its folding into the prion-like [PSI1] structure.
When Hsp104 concentrations are too high, however, the
transition state conformers generated by Hsp104 are
too broadly dispersed to promote assembly into a sub-
structure that is competent for association with preex-
Figure 2. A Model for Yeast Prion Propagation isting [PSI1] elements (Patino et al., 1996). Whatever the
The N-terminal domain of Sup35 or Ure2 acquires an altered confor- precise mechanism may be, the intimate involvement of
mation that can interact with other molecules of the same type, a chaperone in the maintenance of [PSI1] supports the
causing them to adopt the same form. It is not clear whether the
hypothesis that it is due to a heritable protein structure.C-terminal domain is also structurally altered or is inactivated simply
For mammalian prion diseases, the linkage to chaper-by sequestration from its normal associations. Nor is it clear if the
one proteins is still weak, but suggestive (Kenward etrate-limiting step occurs between molecules in solution or as a
process of aggregation (see Horwich and Weissman, 1997). al., 1996). If chaperones are involved in prion diseases,
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they may provide novel mechanisms for therapeutic in- genomic sequence, derived from strain S288C, reveals
several large open reading frames with single nonsensetervention and facilitate the study of the conversion pro-
cess in vitro. codons imbedded within them. If these codons are sup-
pressed in [PSI1] strains, thepattern of gene expressionRecent Biochemical and Cell Biological Support
Just as mammalian PrP is more resistant to proteolytic would be altered. At least one of these mutations is in
a gene, FLO8, that profoundly affects the ability ofdigestion in cells that contain infectious prions, Sup35
is more resistant to digestion in cells that contain the S288C to exploit a specific environmental niche. FLO8
is required for filamentous growth, a foraging mode in-[PSI1] element (Patino et al., 1996; Paushkin et al., 1996)
and Ure2 in cells that contain [URE3] (Masison and Wick- duced when cells are starved for nitrogen (Liu et al.,
1996).ner, 1995). Moreover, just as mammalian PrP is prone
to aggregation in the prion state and is often found in In the natural environment, yeast cells must cope with
changes in temperature, availability of nutrients, compe-large aggregates or ªplaquesº in the brains of infected
animals (Horwich and Weismann, 1997), Sup35 is found tition from other species, ingestion by predators, and
many other variables. [PSI1] might provide a mecha-in large aggregates in [PSI1] strains but is soluble in
[psi2] strains (Patino et al., 1996; Paushkin et al., 1996). nism by which individuals with identical genomes can be
preadapted to different selective niches.The metastableExperimental manipulations that induce [PSI1] or
[URE3] de novo cause a concomitant change in the state character of [PSI1] would ensure that once an organism
has successfully coped with selection, and amplified toof Sup35 and Ure2, as do manipulations that cure cells
of these elements (Masison and Wickner, 1995; Patino a large population size, a small number of individuals
will have arisen that are genetically identical but pre-et al., 1996).
Seeing is believing. Direct, in vivo visualization of the adapted to a different niche. In this context, [PSI1] might
represent not just a mechanism for environmental adap-conversion process was achieved with green fluores-
cent protein (GFP). This protein fluoresces green on tation, but a mechanism to allow the accumulation of
genetic variants, because these are suppressible underexposure to blue light, illuminating the dynamic proper-
ties of other proteins to which it is fused. When GFP different naturally occurring circumstances. Finally, be-
cause [PSI1] is controlled by Hsp104, and becauseattached to the amino-terminal domain of Sup35 is in-
duced in [psi2] cells, it is freely distributed; in [PSI1] Hsp104 is induced by environmental stress, this phe-
nomenon provides the first plausible molecular mecha-cells it rapidly concentrates in a small number of intense
foci. Thus, as predicted by the prion hypothesis, when nism for a cell to respond to its environment with a
heritable change in phenotype.pre-existing Sup35 protein is in the [PSI1] state, it influ-
ences newly synthesized molecules containing the Broader Implications
[PSI1] and [URE3] provide a convincing case that theprion-determining domain to adopt the same altered
state (Patino et al., 1996). Again, experimental manipula- inheritance of phenotype can sometimes be based upon
the inheritance of different protein conformations rathertions that cure cells of [PSI1], or induce it de novo,
cause a concomitant change in the distribution of the than upon the inheritance of different nucleic acids. In
this light, the prion hypothesis for ªmad cowº diseaseGFP fusion protein. When GFP is attached to a different
type of aggregation-prone domain, the pattern of aggre- no longer seems so mad. In fact, yeast prions even
provide a corollary for what is currently themost conten-gation is variable from cell to cell. In contrast, the aggre-
gation pattern of the Sup35±GFP fusion is invariant. tious issue in the prion field, the existence of strains.
(See Horwich and Weissman, 1997, for a description ofWhen mothers contain aggregates, their daughters do
too (Patino et al., 1996). These data strongly bolster mammalian strains, and Derkatch et al., 1996, for the
discovery of yeast strains.) Of course, the oft toutedgenetic arguments that [PSI1] and [URE3] represent
heritable changes in protein conformation. ªawesome power of yeast geneticsº will provide impor-
tant new tools for the study of prion-like processes. ButWhy Do These Elements Exist?
In PrP, amino acids that contribute to prion formation far more importantly, yeast prions instruct us to broaden
greatly the context in which such processes might beare broadly distributed through the protein. With the
yeast prions, however, prion determinants seem re- sought. My parting words, therefore, are meant to be
provocative.stricted to functionally dispensable, adventitious do-
mains. This suggests yeast prions represent a novel, As discussed above, prions need not be pathogenic.
Indeed, I would suggest that self-promoted structuralsometimes beneficial mechanism for environmental ad-
aptation rather than a mechanism of disease. I will frame changes in macromolecules lie at the heart of a wide
variety of normal biological processes, not only epige-the hypothesis for [PSI1]. A similar case could likely be
made for [URE3]. netic phenomena, such as those associated with altered
chromatin structures, but also some normal, develop-Yeast cells rapidly rid themselves of even mildly dele-
terious markers. If the amino-terminal domain of Sup35 mentally regulated events. Developmental switches are
often initiated by high-level expression of a key regula-served only to make cells susceptible to pathogenic
reductions in the fidelity of protein synthesis, it should tor. Once determination is achieved, high level expres-
sion is no longer required. Of course, there may be manynot be maintained. Yet not only is it maintained, it is
conserved (Kushnirov et al., 1990). Since the only known reasons for such a pattern, but among them, in some
cases, may be the need to nucleate an altered proteinfunction of this domain is to make cells susceptible to
[PSI1], the question is: could [PSI1]-mediated non- structure that, once initiated, is self-promoted and heri-
table in the determined lineage. (In this regard, it issense suppression have a beneficial effect that keeps
this domain associated with Sup35? The complete yeast intriguing that many important regulators contain large
Cell
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glutamine- and asparagine-rich domains that look rather
like those of Sup35 and Ure2.) Finally, such processes
needn't be restricted to proteins. RNAs can assume
alternative structures, and it is easy to imagine how such
structures might become self-perpetuating. (A case
worth investigating is Xist RNA, the determining factor
in X-chromosome inactivation that forms an as yet unde-
termined structure surrounding the inactive chromo-
some [Willard, 1996].) My contention is that yeast and
mammalian prions are not oddities in a biological freak
show, but actors in a larger production now playing in
a theater near you.
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